Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

References for PMC Articles for PubMed (Select 19261773)

1.

Self-adjuvanting lipopeptide vaccines.

Moyle PM, Toth I.

Curr Med Chem. 2008;15(5):506-16. Review.

PMID:
18289006
2.

Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.

Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, Harvey NG.

Vaccine. 2007 Dec 17;25(52):8833-42. Epub 2007 Oct 29.

PMID:
18023942
3.

Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens.

Uddowla S, Freytag LC, Clements JD.

Vaccine. 2007 Nov 19;25(47):7984-93. Epub 2007 Oct 2.

4.

Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.

Huang J, Mikszta JA, Ferriter MS, Jiang G, Harvey NG, Dyas B, Roy CJ, Ulrich RG, Sullivan VJ.

Hum Vaccin. 2007 May-Jun;3(3):90-3. Epub 2007 May 13.

5.

Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines.

Alarcon JB, Hartley AW, Harvey NG, Mikszta JA.

Clin Vaccine Immunol. 2007 Apr;14(4):375-81. Epub 2007 Feb 28.

6.

Measles vaccination of macaques by dry powder inhalation.

de Swart RL, LiCalsi C, Quirk AV, van Amerongen G, Nodelman V, Alcock R, Yüksel S, Ward GH, Hardy JG, Vos H, Witham CL, Grainger CI, Kuiken T, Greenspan BJ, Gard TG, Osterhaus AD.

Vaccine. 2007 Jan 26;25(7):1183-90. Epub 2006 Oct 23.

PMID:
17084489
7.

Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine.

Mikszta JA, Dekker JP 3rd, Harvey NG, Dean CH, Brittingham JM, Huang J, Sullivan VJ, Dyas B, Roy CJ, Ulrich RG.

Infect Immun. 2006 Dec;74(12):6806-10. Epub 2006 Oct 9.

8.

Mucosal vaccines: the promise and the challenge.

Neutra MR, Kozlowski PA.

Nat Rev Immunol. 2006 Feb;6(2):148-58. Review.

PMID:
16491139
9.

Noninvasive delivery technologies: respiratory delivery of vaccines.

Sullivan VJ, Mikszta JA, Laurent P, Huang J, Ford B.

Expert Opin Drug Deliv. 2006 Jan;3(1):87-95. Review.

PMID:
16370942
10.

Anthrax vaccine powder formulations for nasal mucosal delivery.

Jiang G, Joshi SB, Peek LJ, Brandau DT, Huang J, Ferriter MS, Woodley WD, Ford BM, Mar KD, Mikszta JA, Hwang CR, Ulrich R, Harvey NG, Middaugh CR, Sullivan VJ.

J Pharm Sci. 2006 Jan;95(1):80-96.

PMID:
16315230
11.

The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles.

Mueller CA, Broz P, Müller SA, Ringler P, Erne-Brand F, Sorg I, Kuhn M, Engel A, Cornelis GR.

Science. 2005 Oct 28;310(5748):674-6.

12.

Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.

Jones T, Adamovicz JJ, Cyr SL, Bolt CR, Bellerose N, Pitt LM, Lowell GH, Burt DS.

Vaccine. 2006 Mar 6;24(10):1625-32. Epub 2005 Oct 7.

PMID:
16243411
13.

Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.

Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, Worsham P, Pullen JK, Ribot W, Hines H, Smith L, Heath DG, Adamovicz JJ.

Biotechnol Prog. 2005 Sep-Oct;21(5):1490-510.

PMID:
16209555
14.

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

Mikszta JA, Sullivan VJ, Dean C, Waterston AM, Alarcon JB, Dekker JP 3rd, Brittingham JM, Huang J, Hwang CR, Ferriter M, Jiang G, Mar K, Saikh KU, Stiles BG, Roy CJ, Ulrich RG, Harvey NG.

J Infect Dis. 2005 Jan 15;191(2):278-88. Epub 2004 Dec 15.

15.

A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.

Huang J, Garmise RJ, Crowder TM, Mar K, Hwang CR, Hickey AJ, Mikszta JA, Sullivan VJ.

Vaccine. 2004 Dec 21;23(6):794-801.

PMID:
15542204
16.

Dose sparing with intradermal injection of influenza vaccine.

Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM.

N Engl J Med. 2004 Nov 25;351(22):2295-301. Epub 2004 Nov 3.

17.

Serum antibody responses after intradermal vaccination against influenza.

Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G.

N Engl J Med. 2004 Nov 25;351(22):2286-94. Epub 2004 Nov 3.

18.

VIRULENCE OF PASTEURELLA PESTIS AND IMMUNITY TO PLAGUE.

BURROWS TW.

Ergeb Mikrobiol Immunitatsforsch Exp Ther. 1963;37:59-113. Review. No abstract available.

PMID:
14324291
19.

Protective efficacy of a fully recombinant plague vaccine in the guinea pig.

Jones SM, Griffin KF, Hodgson I, Williamson ED.

Vaccine. 2003 Sep 8;21(25-26):3912-8.

PMID:
12922126
20.

Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.

Hill J, Copse C, Leary S, Stagg AJ, Williamson ED, Titball RW.

Infect Immun. 2003 Apr;71(4):2234-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk